Editorial

Clinical Microbiology and Infection

Volumn 18, Issue SUPPL. 4, 2012, Pages 1-1

  Raoult, D ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ECOSYSTEM; EDITORIAL; ENVIRONMENTAL FACTOR; FARM ANIMAL; GENE SEQUENCE; INTESTINE FLORA; METAGENOMICS; MICROFLORA; PRIORITY JOURNAL;

EID: 84861680229     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03915.x     Document Type: Editorial

References (19)

1. Alcaraz LD, Belda-Ferre P, Cabrera-Rubio R et al. Identifying a healthy oral microbiome through metagenomics. Clin Microbiol Infect 2012; 18 (suppl 4): 54-57.
2. Mullany P, Allan E, Warburton P. Tetracycline resistance genes and mobile genetic elements from the oral metagenome. Clin Microbiol Infect 2012; 18 (suppl 4): 58-60.
3. Parfrey LW, Knight R. Spatial and temporal variability of the human microbiota. Clin Microbiol Infect 2012; 18 (suppl 4): 5-7.
4. Li L, Norman A, Hansen LH, Sorensen SJ. Metambolomics-expanding our knowledge on the pool of plasmid encoded traits in natural environments using high-throughput sequencing. Clin Microbiol Infect 2012; 18 (suppl 4): 8-11.
5. Marcobal A, Sonnenburg JL. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect 2012; 18 (suppl 4): 12-15.
6. Salonen A, Salojärvi J, Lahti L, de Vos WM. The role of intestinal microbiota and host-microbe interactions in health and disease. Clin Microbiol Infect 2012; 18 (suppl 4): 16-20.
7. Vallès Y, Gosalbes MJ, de Vries LE, Abellán JJ, Francino MP. Metagenomics and development of the gut microbiota in infants. Clin Microbiol Infect 2012; 18 (suppl 4): 21-26.
8. Garmendia L, Hernandez A, Sanchez MB, Martínez JL. Metagenomics and antibiotics. Clin Microbiol Infect 2012; 18 (suppl 4): 27-31.
9. Gueimonde M, Collado MC. Metagenomics and probiotics. Clin Microbiol Infect 2012; 18 (suppl 4): 32-34.
10. O'Toole PW. Changes in the intestinal microbiota from adulthood through to old age. Clin Microbiol Infect 2012; 18 (suppl 4): 44-46.
11. Ukhanova M, Culpepper T, Baer D et al. Gut microbiota correlates with energy gain from dietary fibre and appears to be associated with acute and chronic intestinal diseases. Clin Microbiol Infect 2012; 18 (suppl 4): 61-65.
12. Baquero F. Metagenomic epidemiology: a public health need for the control of antimicrobial resistance. Clin Microbiol Infect 2012; 18 (suppl 4): 66-72.
13. Gutiérrez-Preciado A, Merino E. Elucidating metabolic pathways and digging for genes of unknown function in microbial communities: the riboswitch approach. Clin Microbiol Infect 2012; 18 (suppl 4): 35-39.
14. Bapteste E, Bicep C, Lopez P. Evolution of genetic diversity using networks: the human gut microbiome as a case study. Clin Microbiol Infect 2012; 18 (suppl 4): 40-43.
15. Gosalbes MJ, Abellan JJ, Durbán A, Pérez-Cobas AE, Latorre A, Moya A. Metagenomics of human microbiome: beyond 16s rDNA. Clin Microbiol Infect 2012; 18 (suppl 4): 47-49.
16. Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect 2012; 18 (suppl 4): 50-53.
17. Raoult D. Probiotics and obesity: a link? Nat Rev Microbiol 2009; 7: 616.
18. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012; 7: e34938.
19. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease, Evidence Report/Technology Assessment Number 200. Prepared for the Agency for Healthcare Research and Quality (AHRQ). Available at: Accessed March 2012